What is the price target for ESAB stock?
16 analysts have analysed ESAB and the average price target is 141.82 USD. This implies a price increase of 29.45% is expected in the next year compared to the current price of 109.55.
NYSE:ESAB • US29605J1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ESAB CORP (ESAB).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-16 | DA Davidson | Maintains | Buy -> Buy |
| 2026-04-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-04-08 | Stifel | Maintains | Buy -> Buy |
| 2026-02-23 | Stifel | Maintains | Buy -> Buy |
| 2026-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-03 | Roth Capital | Reiterate | Buy -> Buy |
| 2026-02-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-23 | Stifel | Maintains | Buy -> Buy |
| 2026-01-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-16 | Stifel | Maintains | Buy -> Buy |
| 2025-10-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-20 | UBS | Maintains | Buy -> Buy |
| 2025-10-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-05 | Roth Capital | Initiate | Buy |
| 2025-08-22 | Loop Capital | Upgrade | Hold -> Buy |
| 2025-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-08-07 | Stifel | Upgrade | Hold -> Buy |
| 2025-08-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-21 | Stifel | Maintains | Hold -> Hold |
| 2025-05-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-05-02 | Stifel | Maintains | Hold -> Hold |
| 2025-04-14 | Stifel | Maintains | Hold -> Hold |
| 2025-04-01 | UBS | Upgrade | Neutral -> Buy |
| 2025-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.775B 6.99% | 2.741B -1.22% | 2.843B 3.71% | 3.019B 6.21% | 3.18B 5.33% | 3.402B 6.98% | 3.476B 2.18% | |
| EBITDA YoY % growth | 514.699M 17.97% | 531.603M 3.28% | 523.606M -1.50% | 603.02M 15.17% | 661.42M 9.68% | 749.66M 13.34% | 799.68M 6.67% | |
| EBIT YoY % growth | 439.665M 18.73% | 464.813M 5.72% | 439.501M -5.45% | 531.02M 20.82% | 592.86M 11.65% | 626.12M 5.61% | 741.34M 18.40% | |
| Operating Margin | 15.85% | 16.96% | 15.46% | 17.59% | 18.64% | 18.40% | 21.33% | |
| EPS YoY % growth | 4.46 7.33% | 5.05 13.23% | 5.28 4.55% | 5.95 12.69% | 6.70 12.63% | 7.62 13.69% | 8.27 8.57% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.38 10.03% | 1.54 13.54% | 1.49 13.08% | 1.51 12.07% | 1.60 16.47% | 1.69 9.72% | 1.65 10.66% | 1.70 12.40% | 1.71 6.97% | 1.87 10.17% | 1.76 6.82% | 1.86 9.16% |
| Revenue Q2Q % growth | 733.75M 8.20% | 772.21M 7.91% | 767.31M 5.42% | 756.61M 4.94% | 767.22M 4.56% | 798.16M 3.36% | 791.97M 3.21% | 782.79M 3.46% | 793.58M 3.44% | 834.17M 4.51% | 827.97M 4.55% | 820.71M 4.84% |
| EBITDA Q2Q % growth | 142.48M 8.07% | 153.9M 4.46% | 150.8M -11.14% | 152.05M -19.22% | 157.92M 10.84% | 163.82M 6.45% | 159.3M 5.64% | 163.36M 7.44% | 170.63M 8.05% | 182.95M 11.68% | 174.65M 9.64% | 180.93M 10.76% |
| EBIT Q2Q % growth | 127.12M 11.17% | 134.55M 21.78% | 132.12M 19.06% | 130.39M 25.21% | 139.51M 9.75% | 141.49M 5.16% | 140.23M 6.14% | 136.66M 4.81% | 146.75M 5.19% | 147.11M 3.97% | 144.02M 2.70% | 142.35M 4.16% |
All data in USD
16 analysts have analysed ESAB and the average price target is 141.82 USD. This implies a price increase of 29.45% is expected in the next year compared to the current price of 109.55.
ESAB CORP (ESAB) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of ESAB CORP (ESAB) is 1.38 USD and the consensus revenue estimate is 733.75M USD.
The consensus rating for ESAB CORP (ESAB) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.